Martha J. Carter, Chief Regulatory Officer & SVP at Aegerion Pharmaceuticals, Inc. (AEGR), sold 5,000 shares at $82.81 ($414K) on 2013-11-01, disclosed to the SEC on 2013-11-05.
Scheduled sale ($414k) by Chief Regulatory Officer & SVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ALBO | SELL | 2022-10-25 | $2K | — | Filing → |
| ALBO | SELL | 2022-07-25 | $3K | — | Filing → |
| ALBO | SELL | 2022-04-25 | $3K | — | Filing → |